Mice Model Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By End Users, By Region, By Competition, 2020-2030F

Description

The Global Mice Model Technologies Market, valued at USD 1.35 Billion in 2024, is projected to experience a CAGR of 10.3% to reach USD 2.43 Billion by 2030. Mice model technologies encompass the development, production, and application of genetically modified or inbred mouse strains as *in vivo* tools for biomedical research, drug discovery, and toxicology studies. Key drivers supporting this market's growth include increasing research and development investments within the pharmaceutical and biotechnology sectors, the rising demand for personalized medicine approaches, and continuous advancements in genetic engineering techniques such as CRISPR/Cas9, which enable more precise disease modeling.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.35 Billion
Market Size 2030	USD 2.43 Billion
CAGR 2025-2030	10.3%
Fastest Growing Segment	CRISPR Knockout
Largest Market	North America

Key Market Drivers

The escalating global prevalence of chronic diseases acts as a primary catalyst for growth within the mice model technologies market. Conditions such as cancer, diabetes, and neurological disorders necessitate extensive research to elucidate pathogenesis, identify therapeutic targets, and develop effective treatments. Mice models are indispensable tools, providing physiologically relevant *in vivo* systems for disease modeling and drug efficacy testing. The increased burden of these diseases drives demand for specialized mouse models that accurately recapitulate human disease phenotypes. For instance, according to the National Cancer Institute, in an article dated April 4, 2024, "Fiscal Year 2024 Appropriation - NCI", the total appropriation for NCI in fiscal year 2024 was $7.22 billion for cancer research, fueling the application of advanced mouse models crucial for oncology investigations.

Key Market Challenges

A significant challenge impeding the growth of the Global Mice Model Technologies Market is the stringent ethical considerations and regulatory frameworks governing animal welfare in research. These frameworks impose substantial administrative burdens and increased operational costs on research institutions and pharmaceutical companies involved in developing and utilizing mouse models. Navigating complex approval processes for animal studies can extend timelines for drug discovery and toxicology assessments, thereby slowing the development and application of new mouse models.

Key Market Trends

The increasing development of humanized mice models is a significant trend, driven by the need for preclinical tools that more closely mimic human physiology and disease. These models enhance the translational relevance of drug discovery and development, especially in oncology, immunology, and infectious diseases. Charles River Laboratories, in December 2023, highlighted advancements in next-generation humanized models through CRISPR-mediated genetic modification, expanding their utility for immuno-oncology research.

Key Market Players

Biocytogen LLC
Charles River Laboratories Inc.
Cyagen Biosciences
GemPharmatech Co Ltd.
genOway S.A.
Ingenious Targeting Laboratory Inc.
Merck KGaA.
Ozgene Pty Ltd.
Taconic Biosciences Inc.
Polygena AG

Report Scope:

In this report, the Global Mice Model Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mice Model Technologies Market, By Technology:

CRISPR Knockout
Random Insertions
Large and Targeted Insertions
ES Cell Modification (Homologous Recombination)
Others

Mice Model Technologies Market, By End Users:

Pharmaceutical Companies
Biotechnology Companies
Academic and Research Facilities
Contract Research and Manufacturing Organizations

Mice Model Technologies Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Mice Model Technologies Market.

Available Customizations:

Global Mice Model Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Mice Model Technologies Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Technology (CRISPR Knockout, Random Insertions, Large and Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)
- 5.2.2. By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Mice Model Technologies Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Technology
- 6.2.2. By End Users
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Mice Model Technologies Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Technology
    - 6.3.1.2.2. By End Users
- 6.3.2. Canada Mice Model Technologies Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Technology
    - 6.3.2.2.2. By End Users
- 6.3.3. Mexico Mice Model Technologies Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Technology
    - 6.3.3.2.2. By End Users

7. Europe Mice Model Technologies Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Technology
- 7.2.2. By End Users
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Mice Model Technologies Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Technology
    - 7.3.1.2.2. By End Users
- 7.3.2. France Mice Model Technologies Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Technology
    - 7.3.2.2.2. By End Users
- 7.3.3. United Kingdom Mice Model Technologies Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Technology
    - 7.3.3.2.2. By End Users
- 7.3.4. Italy Mice Model Technologies Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Technology
    - 7.3.4.2.2. By End Users
- 7.3.5. Spain Mice Model Technologies Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Technology
    - 7.3.5.2.2. By End Users

8. Asia Pacific Mice Model Technologies Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Technology
- 8.2.2. By End Users
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Mice Model Technologies Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Technology
    - 8.3.1.2.2. By End Users
- 8.3.2. India Mice Model Technologies Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Technology
    - 8.3.2.2.2. By End Users
- 8.3.3. Japan Mice Model Technologies Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Technology
    - 8.3.3.2.2. By End Users
- 8.3.4. South Korea Mice Model Technologies Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Technology
    - 8.3.4.2.2. By End Users
- 8.3.5. Australia Mice Model Technologies Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Technology
    - 8.3.5.2.2. By End Users

9. Middle East & Africa Mice Model Technologies Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Technology
- 9.2.2. By End Users
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Mice Model Technologies Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Technology
    - 9.3.1.2.2. By End Users
- 9.3.2. UAE Mice Model Technologies Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Technology
    - 9.3.2.2.2. By End Users
- 9.3.3. South Africa Mice Model Technologies Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Technology
    - 9.3.3.2.2. By End Users

10. South America Mice Model Technologies Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Technology
- 10.2.2. By End Users
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Mice Model Technologies Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Technology
    - 10.3.1.2.2. By End Users
- 10.3.2. Colombia Mice Model Technologies Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Technology
    - 10.3.2.2.2. By End Users
- 10.3.3. Argentina Mice Model Technologies Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Technology
    - 10.3.3.2.2. By End Users

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Mice Model Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Biocytogen LLC
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Charles River Laboratories Inc.
15.3. Cyagen Biosciences
15.4. GemPharmatech Co Ltd.
15.5. genOway S.A.
15.6. Ingenious Targeting Laboratory Inc.
15.7. Merck KGaA.
15.8. Ozgene Pty Ltd.
15.9. Taconic Biosciences Inc.
15.10. Polygena AG